Company: RNGE
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001343
Chunk: 472

Company: RANGE IMPACT, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 4
Chunk 472
---
  
     0.35  
    5/8/2029

    12/10/2021 
     150,000  
     -  
     0.277  
    12/10/2031

    11/30/2022 
     250,000  
        
     0.18  
    11/30/2032

    (1)
    Granted
                                            under the Company’s Equity Incentive Plan, the awards consist of (i) an option to purchase
                                            500,000 shares of common stock, 250,000 of which became fully exercisable in May 2020 and
                                            250,000 of which became fully exercisable in May 2021, (ii) an option to purchase 250,000
                                            shares of common stock, 125,000 of which became fully exercisable in June 2020 and 125,000
                                            of which became fully exercisable in June 2021, (iii) an option to purchase 350,000 shares
                                            of common stock, all of which became fully exercisable in December 2021, (iv) an option to
                                            purchase 750,000 shares of common stock all of which became fully exercisable in November
                                            2022, and (v) an option to purchase 1,000,000 shares of common stock all of which became
                                            fully exercisable in December 2023.

    (2)
    Granted
    under the Company’s Equity Incentive Plan, the award consists of an option to purchase 250,000 shares of common stock, half
    which became fully exercisable in April 2024.

    (3)
    Granted
    under the Company’s Equity Incentive Plan, the awards consist of (i) an option to purchase 370,234 shares of common stock,
    all of which became fully exercisable in July 2018, (ii) an option to purchase 250,000 shares of common stock, 125,000 of which became
    fully exercisable in June 2020 and 125,000 of which became fully exercisable in June 2021, (iii) an option to purchase 150,000 shares
    of common stock, all of which became fully exercisable in December 2021, and (iv) an option to purchase 250,000 shares of common
    stock